Home Journals Articles Updates About
CN
image
收藏切换
Research progress on therapeutic drugs for corona virus disease 2019
收藏切换
PDF
Lu YANG1, 2, Hui-qiang WANG1, 2, Yu-huan LI1, 2
Acta Pharmaceutica Sinica | 2020, 55(6) : 1081 - 1090
Less
收藏切换
Acta Pharmaceutica Sinica | 2020, 55(6): 1081-1090
• Anti Novel Coronavirus Drugs Researchs •
Research progress on therapeutic drugs for corona virus disease 2019
Full
Lu YANG1, 2, Hui-qiang WANG1, 2, Yu-huan LI1, 2
Affiliations
  • 1. Key Laboratory of Antiviral Drugs, Chinese Academy of Medical Sciences, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
  • 2. Beijing Key Laboratory of Anti-Infective Drugs, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2020-06-12 doi: 10.16438/j.0513-4870.2020-0324
Outline
收藏切换

Corona virus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. At present, there is no specific antiviral drug for this virus, and the main clinical treatment is support and symptomatic treatment. Direct targeting the virus and the host targets are two strategies for the development of antiviral drugs. At present, the research and development of COVID-19 therapeutic drugs has made some progress on both approaches. Here we review potential anti-SARS-CoV-2 drugs to discuss the antiviral mechanisms and potential of these drugs from the perspectives of virus and host. The role of traditional Chinese medicine in the treatment of COVID-19 is discussed along with the prospects for drug treatment strategies of COVID-19.

severe acute respiratory syndrome coronavirus 2  /  corona virus disease 2019  /  antiviral drug  /  mechanism
Lu YANG, Hui-qiang WANG, Yu-huan LI. Research progress on therapeutic drugs for corona virus disease 2019[J]. Acta Pharmaceutica Sinica, 2020 , 55 (6) : 1081 -1090 . DOI: 10.16438/j.0513-4870.2020-0324
Appendix
Less
Year 2020 volume 55 Issue 6
PDF
100
41
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-0324
  • Receive Date：2020-03-13
  • Online Date：2026-01-21
  • Published：2020-06-12
Article Data
Affiliations
History
  • Received：2020-03-13
  • Revised：2020-04-07
Funding
Affiliations
    1. Key Laboratory of Antiviral Drugs, Chinese Academy of Medical Sciences, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
    2. Beijing Key Laboratory of Anti-Infective Drugs, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-0324
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House